These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 28496655)

  • 1. Electrophysiological Changes of the Atrium in Patients with Lone Paroxysmal Atrial Fibrillation.
    Centurion OA; Isomoto S; Shimizu A
    J Atr Fibrillation; 2010; 3(1):232. PubMed ID: 28496655
    [No Abstract]   [Full Text] [Related]  

  • 2. Atrial vulnerability in patients with paroxysmal "lone" atrial fibrillation.
    Zimmermann M; Adamec R; Metzger J
    Pacing Clin Electrophysiol; 1998 Oct; 21(10):1949-58. PubMed ID: 9793092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Electrophysiological abnormalities of the atrial muscle in patients with paroxysmal atrial fibrillation associated with hyperthyroidism.
    Komiya N; Isomoto S; Nakao K; Hayano M; Yano K
    Clin Endocrinol (Oxf); 2002 Jan; 56(1):39-44. PubMed ID: 11849245
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Electrophysiological properties of the left atrium evaluated by coronary sinus pacing in patients with atrial fibrillation.
    Ishimatsu T; Hayano M; Hirata T; Iliev II; Komiya N; Nakao K; Iwamoto K; Tsukahara K; Sakamoto R; Ueyama C; Yano K
    Pacing Clin Electrophysiol; 1999 Dec; 22(12):1739-46. PubMed ID: 10642126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Further evidence of localized posterior interatrial conduction delay in lone paroxysmal atrial fibrillation.
    Platonov PG; Yuan S; Hertervig E; Kongstad O; Roijer A; Vygovsky AB; Chireikin LV; Olsson SB
    Europace; 2001 Apr; 3(2):100-7. PubMed ID: 11333046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Electrophysiological Cardiac Parameters and Results of Antiarrhythmic Treatment in Patients with Paroxysmal Atrial Fibrillation (Lone and Associated with Arterial Hypertension)].
    Mironova ES; Mironov NY; Mironova NA; Novikov PS; Novikov IA; Layovich LY; Maykov EB; Golitsyn SP
    Kardiologiia; 2019 Aug; 59(8):39-46. PubMed ID: 31397228
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical significance of the atrial fibrillation threshold in patients with paroxysmal atrial fibrillation.
    Inoue K; Shirayama T; Shiraishi H; Matoba Y; Imai H; Inoue D; Nakagawa M
    Pacing Clin Electrophysiol; 2001 May; 24(5):796-805. PubMed ID: 11388098
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Wavelength and atrial vulnerability: an endocavitary approach in humans.
    Graux P; Carlioz R; Rivat P; Bera J; Guyomar Y; Dutoit A
    Pacing Clin Electrophysiol; 1998 Jan; 21(1 Pt 2):202-8. PubMed ID: 9474673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of stimulation and blockade of the autonomic nervous system on atrial refractoriness in patients with lone paroxysmal atrial fibrillation.
    Oliveira MM; da Silva N; Feliciano J; Timóteo A; Marques F; Santos S; Rocha I; Silva-Carvalho L; Ferreira R
    Rev Port Cardiol; 2009 Jun; 28(6):655-70. PubMed ID: 19697794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced dispersion of atrial refractoriness as an electrophysiological substrate for vulnerability to atrial fibrillation in patients with paroxysmal atrial fibrillation.
    Oliveira MM; da Silva N; Timóteo AT; Feliciano J; de Sousa L; Santos S; Marques F; Ferreira R
    Rev Port Cardiol; 2007; 26(7-8):691-702. PubMed ID: 17939579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Electrophysiologic effects of a class I antiarrhythmic agent, cibenzoline, on the refractoriness and conduction of the human atrium in vivo.
    Esato M; Shimizu A; Chun YH; Tatsuno H; Yamagata T; Matsuzaki M
    J Cardiovasc Pharmacol; 1996 Aug; 28(2):321-7. PubMed ID: 8856490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sick sinus syndrome with and without atrial fibrillation: atrial refractoriness and conduction characteristics.
    De Sisti A; Leclercq JF; Fiorello P; Di Lorenzo M; Manot S; Halimi F; Attuel P
    Cardiologia; 1999 Apr; 44(4):361-7. PubMed ID: 10371788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Electrophysiological determinants of atrial fibrillation in sinus node dysfunction despite atrial pacing.
    De Sisti A; Attuel P; Manot S; Fiorello P; Halimi F; Leclercq JF
    Europace; 2000 Oct; 2(4):304-11. PubMed ID: 11194597
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paroxysmal lone atrial fibrillation is associated with an abnormal atrial substrate: characterizing the "second factor".
    Stiles MK; John B; Wong CX; Kuklik P; Brooks AG; Lau DH; Dimitri H; Roberts-Thomson KC; Wilson L; De Sciscio P; Young GD; Sanders P
    J Am Coll Cardiol; 2009 Apr; 53(14):1182-91. PubMed ID: 19341858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Electrophysiological properties in patients undergoing atrial compartment operation for chronic atrial fibrillation with mitral valve disease.
    Lo HM; Lin FY; Lin JL; Tseng CD; Hsu KL; Chiang FT; Tseng YZ
    Eur Heart J; 1997 Nov; 18(11):1805-15. PubMed ID: 9402456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Paroxysmal atrial fibrillation is associated with increased intra-atrial conduction delay.
    Pytkowski M; Jankowska A; Maciag A; Kowalik I; Sterlinski M; Szwed H; Saumarez RC
    Europace; 2008 Dec; 10(12):1415-20. PubMed ID: 18936043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intra-atrial conduction delay and fragmented atrial activity in patients with paroxysmal atrial fibrillation.
    Shimizu A; Fukatani M; Tanigawa M; Mori M; Hashiba K
    Jpn Circ J; 1989 Sep; 53(9):1023-30. PubMed ID: 2600995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Electrophysiological abnormalities in patients with paroxysmal atrial fibrillation in the absence of overt structural heart disease.
    Arroja JD; Burri H; Park CI; Giraudet P; Zimmermann M
    Indian Pacing Electrophysiol J; 2016; 16(5):152-156. PubMed ID: 27979373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Electrophysiological properties in chronic lone atrial fibrillation.
    Kumagai K; Akimitsu S; Kawahira K; Kawanami F; Yamanouchi Y; Hiroki T; Arakawa K
    Circulation; 1991 Oct; 84(4):1662-8. PubMed ID: 1914105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The spatial dispersion of atrial refractoriness and atrial fibrillation vulnerability.
    Roithinger FX; Karch MR; Steiner PR; SippensGroenewegen A; Lesh MD
    J Interv Card Electrophysiol; 1999 Dec; 3(4):311-9. PubMed ID: 10525245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.